Fibroblasts isolated from human pterygia exhibit altered lipid metabolism characteristics

Experimental Eye Research

Volumn 83, Issue 3, 2006, Pages 536-542

  Peiretti, Enrico ^a   Dessì, Sandra ^a   Mulas, Maria F ^a   Abete, Claudia ^a   Galantuomo, Maria S ^a   Fossarello, Maurizio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

antiproliferative drugs; cholesterol metabolism; fibroblasts; lipid metabolism; pterygium

Indexed keywords

CARBON 14; CHOLESTEROL ESTER; EVEROLIMUS; KI 67 ANTIGEN; OLEIC ACID; PIOGLITAZONE; PROTEIN P53; THYMIDINE; TRITIUM;

ADULT; AGED; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; FROZEN SECTION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM;

AGED; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; CHOLESTEROL; CONJUNCTIVA; ESTERS; FEMALE; FIBROBLASTS; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PTERYGIUM; SIROLIMUS; THIAZOLIDINEDIONES;

EID: 33745145435     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.02.005     Document Type: Article

References (28)

1. Batetta B., Mulas M.F., Petruzzo P., et al. Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell. Mol. Life Sci. 58 (2001) 1113-1120
2. Batetta B., Mulas M.F., and Sanna F. Role of cholesterol ester pathway in the control of cell cycle in human aortic smooth muscle cells. FASEB J. 17 (2003) 746-748 Epub 2003
3. Chen J.K., Tsai R.J., and Linn S.S. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell. Dev. Biol. Anim. 30A (1994) 243-248
4. Clayton P.T. Disorders of cholesterol biosynthesis. Arch. Dis. Child. 78 (1998) 185-189
5. Clear A.S., Chirambo M.C., and Hutt M.S.R. Solar keratosis, pterygium and squamous cell carcinoma of the conjunctiva in Malawi. Br. J. Ophthalmol. 63 (1979) 102-109
6. Coroneo M.T., DiGirolamo N., and Wakefield D. The pathogenesis of pterygia. Curr. Opin. Ophthalmol. 10 (1999) 282-288
7. Dessi S., Batetta B., Pulisci D., et al. Altered pattern of lipid metabolism in patients with lung cancer. Oncology 49 (1992) 436-441
8. Dessi S., Batetta B., Pulisci D., et al. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73 (1994) 253-258
9. Dushku N., and Reid T.W. Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr. Eye Res. 13 (1994) 473-481
10. Dushku N., John M.K., Schultz G.S., and Reid T.W. Pterygia pathogenesis. Arch. Ophthalmol. 119 (2001) 695-706
11. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N. Engl. J. Med. 28 349 (2003) 847-858
12. Feb Wakino S., Kintscher U., Kim S., Yin F., Hsueh W.A., and Law R.E. Peroxisome proliferator-activated receptor-γ ligands inhibit Rb phosphorylation and G1 → S transition in vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 22435-22441
13. Hainaut P., and Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77 (2000) 81-173
14. Igarashi M., Hirata A., Yamaguchi H., et al. Characterization of an Inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth. Metabolism 50 (2001) 955-962
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin-phenol reagents. J. Biol. Chem. 193 (1951) 265-275
16. Marx N., Schonbeck U., Lazar M.A., Libby P., and Plutzky J. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ. Res. 83 (1998) 1097-1103
17. Mazzone T., Basheeruddin K., Ping L., and Schick C. Relation of growth- and sterol-related regulatory pathways for low density lipoprotein receptor gene expression. J. Biol. Chem. 265 (1990) 5145-5149
18. Nashan B. Review of the proliferation inhibitor everolimus. Expert Opin. Investig. Drugs 12 (2002) 1845-1857
19. Nolan T.M., DiGirolamo N., Sachdev N.H., Hampartzoumian T., Coroneo M.T., and Wakefield D. The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. Am. J. Pathol. 162 (2003) 567-574
20. Peiretti E., Dessi S., Putzolu M., and Fossarello M. Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3982-3985
21. Petruzzo P., Cappai A., Brotzu G., et al. Lipid metabolism and molecular changes in normal and atherosclerotic vessels. Eur. J. Vasc. Endovasc. Surg. 22 (2001) 31-36
22. Pharmakakis N., and Assimakopoulou M. Immunohistochemical detection of heat shock protein 27 and Ki-67 in human pterygium. Br. J. Ophthalmol. 85 (2001) 1392-1393
23. Spandidos D.A., Sourvinos G., Kiaris H., and Tsamparlakis J. Microsatellite instability and loss of heterozygosity in human pterygia. Br. J. Ophthalmol. 81 (1997) 493-496
24. Tan D.T., Lim A.S., Goh H.S., and Smith D.R. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva in patients with pterygium. Am. J. Ophthalmol. 23 (1997) 404-405
25. Tan D.T., Chee S.P., Dear K.B., and Lim A.S. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch. Ophthalmol. 115 (1997) 1235-1240
26. Tan D.T., Liu Y.P., and Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1684-1686
27. Tsai Y.Y., Chang K.C., Lin C.L., et al. p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea 24 (2005) 583-586
28. Weinstein O., Rosenthal G., Zirkin H., Monos T., Lifshitz T., and Argov S. Overexpression of p53 tumor suppressor gene in pterygia. Eye 16 (2002) 619-621